GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity

Tetsuhide Ito, Hisato Igarashi, Tapas K. Pradhan, Wei Hou, Samuel A. Mantey, John E. Taylor, William A. Murphy, D.H. Coy, Robert T. Jensen

Peptides · 2001 · 16 citations · 71 references

Concepts

References

71